{
  "docId": "019de077-0326-7579-845c-ff13347b3147",
  "docSlug": "a6759fd47798a8f3f6e744ad8917865e",
  "documentTitle": "Exscientia | Investor Presentation Deck | 93 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 92,
  "pageCount": 93,
  "prevPage": 91,
  "nextPage": 93,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-0326-7579-845c-ff13347b3147/92",
  "deckHref": "/decks/019de077-0326-7579-845c-ff13347b3147",
  "deckJsonHref": "/decks/019de077-0326-7579-845c-ff13347b3147.json",
  "deckAnchorHref": "/decks/019de077-0326-7579-845c-ff13347b3147#slide-92",
  "components": [
    {
      "bbox": {
        "h": 0.461,
        "w": 0.415,
        "x": 0.053,
        "y": 0.438
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49663a29-9333-45e2-b84e-17df2220ba4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.522,
        "w": 0.45,
        "x": 0.493,
        "y": 0.308
      },
      "kind": "list",
      "text": "Potent and highly selective MALT1 allosteric inhibitor with low UGT1A1 inhibition risk\nSuitable therapeutic index established\nPotential in broad range of haematologic malignancies\nPotential in combination with BTKi for the prevention and treatment of BTKi-resistant disease\nPotent activity on primary human B-cell lymphoma patient cells; ongoing studies in other indications",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e87c6d4-d55c-43a7-8873-6606fead1802",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.139,
        "w": 0.389,
        "x": 0.077,
        "y": 0.228
      },
      "kind": "list",
      "text": "GLP-tox studies in progress\nCMC work underway",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbcd8a9a-5943-4080-8068-ee4c25b87d7c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.205,
        "x": 0.493,
        "y": 0.242
      },
      "kind": "title",
      "text": "Programme Highlights:",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d136ef7d-9e3e-42a5-a6a5-3093b1ab53e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.056,
        "w": 0.292,
        "x": 0.077,
        "y": 0.067
      },
      "kind": "title",
      "text": "‘565: Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ebffbe08-b115-4057-931b-f70985c3c32b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "2e13ddf2-3345-46ac-aacb-57e62e597b24",
      "evidence": "The summary of key points for '565, including its characteristics and development status, serves as an executive summary.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}